Gene expression profiling of E2F-1-induced apoptosis.

It has been shown that adenovirus-mediated overexpression of E2F-1 can efficiently induce apoptosis in cancer cells with little effect on normal cells. However, the mechanisms by which E2F-1 induces apoptosis remains poorly understood. The goal of this study was to evaluate changes in gene expression in response to E2F-1 in order to help elucidate the mechanisms by which E2F-1 causes apoptosis. Therefore, we used a quantitative microarray assay to identify the genes regulated by E2F-1 in melanoma cells. By gene expression profiling, we first screened a proprietary list of about 12,000 genes. Overexpression of E2F-1 in melanoma cells resulted in two-fold or greater alteration in the level of expression of 452 genes compared to vehicle-treated control cells. Most of the affected genes were not known to be responsive to E2F-1 prior to this study. E2F-1 adenoviral infection of these cells was found to affect the expression of a diverse range of genes, including oncogenes, transcription factors and genes involved in signal transduction, cell cycle regulation, cell proliferation and apoptosis, as well as other genes with unknown function. Changes in expression of 17 of these genes were confirmed by quantitative real-time polymerase chain reaction (PCR). This is first application of the microarray technique in the study of the global profile of genes regulated by E2F-1 in melanoma cells. This study leads to an increased understanding of the biochemical pathways involved in E2F-1-induced apoptosis and possibly to the identification of new therapeutic targets.

[1]  N. L. La Thangue,et al.  A new component of the transcription factor DRTF1/E2F , 1993, Nature.

[2]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[3]  K. McMasters,et al.  Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. , 2002, Cancer research.

[4]  F. Marumo,et al.  Roles of E2F1 in mesangial cell proliferation in vitro. , 1999, Kidney international.

[5]  T. Liu,et al.  Adenovirus‐mediated E2F‐1 gene transfer efficiently induces apoptosis in melanoma cells , 1999, Cancer.

[6]  Guoying Liu,et al.  NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..

[7]  L. Ellis,et al.  Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis , 2002, Oncogene.

[8]  W. Lee,et al.  Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis , 1994, Molecular and cellular biology.

[9]  Y. Kalma,et al.  E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis , 2002, Oncogene.

[10]  Y. Kalma,et al.  Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2 , 2001, Oncogene.

[11]  T. Liu,et al.  Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines , 1999, Cancer Gene Therapy.

[12]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[13]  W. Kaelin,et al.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Giordano,et al.  Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. , 1994, Cancer research.

[15]  K. Hunt,et al.  P53 Carcinoma Cell Lines and Does Not Require Factor E2f-1 Induces Apoptosis in Human Breast and Ovarian Adenovirus-mediated Overexpression of the Transcription Updated Version Citing Articles E-mail Alerts Adenovirus-mediated Overexpression of the Transcription Factor E2f-1 Induces Apoptosis in Hum , 2013 .

[16]  P. Hersey,et al.  The chemoresistance of human malignant melanoma: an update. , 1999, Melanoma research.

[17]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[18]  Yihong Ma,et al.  Identification of novel E2F1-regulated genes by microarray. , 2002, Archives of biochemistry and biophysics.

[19]  J. Nevins,et al.  E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis , 1995, Journal of virology.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  R. Halaban,et al.  Deregulated E2f Transcriptional Activity in Autonomously Growing Melanoma Cells , 2000, The Journal of experimental medicine.

[22]  K. Helin,et al.  Induction of DNA synthesis and apoptosis are separable functions of E2F-1. , 1997, Genes & development.

[23]  W. El-Deiry,et al.  p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. , 1999, International journal of oncology.

[24]  M. Kasten,et al.  pRb and the Cdks in apoptosis and the cell cycle , 1998, Cell Death and Differentiation.

[25]  Brigitte M Pützer,et al.  Gene expression changes in response to E2F1 activation. , 2002, Nucleic acids research.

[26]  D. Banerjee,et al.  Role of E2F-1 in chemosensitivity. , 1998, Cancer research.

[27]  R. Spang,et al.  Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis , 2001, Molecular and Cellular Biology.

[28]  N. Dyson.  The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[29]  J. Nevins,et al.  Specificity in the activation and control of transcription factor E2F-dependent apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Lee,et al.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F , 1992, Molecular and cellular biology.

[31]  M. Atkins,et al.  The treatment of metastatic melanoma with chemotherapy and biologics. , 1997, Current opinion in oncology.

[32]  F. Christians,et al.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. , 2001, Genes & development.

[33]  W. Hong,et al.  Overexpression of E2F‐1 in rat embryo fibroblasts leads to neoplastic transformation. , 1994, The EMBO journal.

[34]  B. A. French,et al.  Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. , 1994, Circulation.

[35]  J. Cidlowski,et al.  Cell cycle and apoptosis: Common pathways to life and death , 1995, Journal of cellular biochemistry.

[36]  C. Peng,et al.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation , 1994, Molecular and cellular biology.

[37]  K. McMasters,et al.  E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  D. Livingston,et al.  Multiple members of the E2F transcription factor family are the products of oncogenes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[40]  K. Helin,et al.  Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. , 1993, Genes & development.

[41]  J. Nevins,et al.  Regulation of the cyclin E gene by transcription factor E2F1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Peters,et al.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.